Enzo Biochem (ENZ) executive Erfanian received 260,000 shares

Insider transactions reported

Hamid Erfanian (executive at Enzo Biochem Inc., ENZ) reported that they received 260,000 shares on Nov 8, 2021. After these transactions the filing shows 260,000 shares held directly.

Reporting person

Erfanian Hamid

Options and other derivatives

Holdings before and after

• Common Stock, $0.01 Par Value: 0 to 260,000 direct
• Stock Option (to acquire Common Stock): 0 to 700,000 direct

Footnotes from the filing

1. 1. The Reporting Person was granted Restricted Stock Units that will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 8, 2022.
2. 2. The Reporting Person was granted 700,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 8, 2022.

Transaction codes in this filing

Grant or award:

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ